Revisiting a selection of target genes for the hematopoietic transcription factor c-Myb using chromatin immunoprecipitation and c-Myb knockdown

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 3, 2007, Pages 278-286

  Berge, Tone ^a,b   Matre, Vilborg ^a   Brendeford, Elen M ^a   Sæther, Thomas ^a   Lüscher, Bernhard ^b   Gabrielsen, Odd Stokke ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

c Myb; ChIP; siRNA; Target gene

Indexed keywords

ADA PROTEIN; MAT2A PROTEIN; PROTEIN; PROTEIN C MYB; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ADENOSINE DEAMINASE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENE SILENCING; HEMATOPOIESIS; HUMANS; LOCUS CONTROL REGION; METHIONINE ADENOSYLTRANSFERASE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-MYC;

VERTEBRATA;

EID: 34748833449     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.05.007     Document Type: Article

References (56)

1. Oh I.H., and Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 18 (1999) 3017-3033
2. Berge T., Bergholtz S.L., Andersson K.B., and Gabrielsen O.S. A novel yeast system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element. Nucleic Acids Res. 29 (2001) E99
3. Ording E., Bergholtz S., Brendeford E.M., Jamin N., and Gabrielsen O.S. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain-In vitro and in vivo analysis. Oncogene 13 (1996) 1043-1051
4. Ganter B., Chao S.T., and Lipsick J.S. Transcriptional activation by the myb proteins requires a specific local promoter structure. FEBS Lett. 460 (1999) 401-410
5. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., Pietryga D.W., Scott W.J.J., and Potter S.S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65 (1991) 677-689
6. Allen III R.D., Bender T.P., and Siu G. c-Myb is essential for early T cell development. Genes Dev. 13 (1999) 1073-1078
7. Bender T.P., Kremer C.S., Kraus M., Buch T., and Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat. Immunol. 5 (2004) 721-729
8. Thomas M.D., Kremer C.S., Ravichandran K.S., Rajewsky K., and Bender T.P. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23 (2005) 275-286
9. Emambokus N., Vegiopoulos A., Harman B., Jenkinson E., Anderson G., and Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J. 22 (2003) 4478-4488
10. Rushton J.J., Davis L.M., Lei W., Mo X., Leutz A., and Ness S.A. Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22 (2003) 308-313
11. Lei W., Rushton J.J., Davis L.M., Liu F., and Ness S.A. Positive and negative determinants of target gene specificity in myb transcription factors. J. Biol. Chem. 279 (2004) 29519-29527
12. Lang G., White J.R., Argent-Katwala M.J., Allinson C.G., and Weston K. Myb proteins regulate the expression of diverse target genes. Oncogene 24 (2005) 1375-1384
13. Matre V., Hovring P.I., Fjeldheim A.K., Helgeland L., Orvain C., Andersson K.B., Gautvik K.M., and Gabrielsen O.S. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb. Biochem. J. 372 (2003) 851-859
14. Boyd K.E., and Farnham P.J. Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222 (1999) 9-28
15. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
16. Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C., and Yamamoto K.R. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15603-15608
17. Tanaka T., Tomaru Y., Nomura Y., Miura H., Suzuki M., and Hayashizaki Y. Comprehensive search for HNF-1beta-regulated genes in mouse hepatoma cells perturbed by transcription regulatory factor-targeted RNAi. Nucleic Acids Res. 32 (2004) 2740-2750
18. Hedvat C.V., Yao J., Sokolic R.A., and Nimer S.D. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J. Biol. Chem. 279 (2004) 6395-6400
19. Lipsick J.S., and Wang D.M. Transformation by v-Myb. Oncogene 18 (1999) 3047-3055
20. Ness S.A. The Myb oncoprotein: regulating a regulator. Biochim. Biophys. Acta 1288 (1996) F123-F139
21. Nakata Y., Shetzline S., Sakashita C., Kalota A., Rallapalli R., Rudnick S.I., Zhang Y., Emerson S.G., and Gewirtz A.M. c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression. Mol. Cell. Biol. 27 (2007) 2048-2058
22. Eberhardy S.R., D'Cunha C.A., and Farnham P.J. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J. Biol. Chem. 275 (2000) 33798-33805
23. Strutt H., and Paro R. Mapping DNA target sites of chromatin proteins in vivo by formaldehyde crosslinking. Methods Mol. Biol. 119 (1999) 455-467
24. Opalinska J.B., Kalota A., Gifford L.K., Lu P., Jen K.Y., Pradeepkumar P.I., Barman J., Kim T.K., Swider C.R., Chattopadhyaya J., and Gewirtz A.M. Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules. Nucleic Acids Res. 32 (2004) 5791-5799
25. Sleeman J.P. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8 (1993) 1931-1941
26. Nicolaides N.C., Gualdi R., Casadevall C., Manzella L., and Calabretta B. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol. 11 (1991) 6166-6176
27. Zeng Z., Yang H., Huang Z.Z., Chen C., Wang J., and Lu S.C. The role of c-Myb in the up-regulation of methionine adenosyltransferase 2A expression in activated Jurkat cells. Biochem. J. 353 (2001) 163-168
28. Ku D.H., Wen S.C., Engelhard A., Nicolaides N.C., Lipson K.E., Marino T.A., and Calabretta B. c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene. J. Biol. Chem. 268 (1993) 2255-2259
29. Oelgeschlager M., Nuchprayoon I., Luscher B., and Friedman A.D. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16 (1996) 4717-4725
30. Zobel A., Kalkbrenner F., Guehmann S., Nawrath M., Vorbrueggen G., and Moelling K. Interaction of the v- and c-Myb proteins with regulatory sequences of the human c-myc gene. Oncogene 6 (1991) 1397-1407
31. Nakagoshi H., Kanei-Ishii C., Sawazaki T., Mizuguchi G., and Ishii S. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7 (1992) 1233-1240
32. Schmidt M., Nazarov V., Stevens L., Watson R., and Wolff L. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol. Cell. Biol. 20 (2000) 1970-1981
33. Reizis B., and Leder P. The upstream enhancer is necessary and sufficient for the expression of the pre-T cell receptor alpha gene in immature T lymphocytes. J. Exp. Med. 194 (2001) 979-990
34. Ess K.C., Whitaker T.L., Cost G.J., Witte D.P., Hutton J.J., and Aronow B.J. A central role for a single c-Myb binding site in a thymic locus control region. Mol. Cell. Biol. 15 (1995) 5707-5715
35. Yang H., Huang Z.Z., Wang J., and Lu S.C. The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. FASEB J. 15 (2001) 1507-1516
36. Aronow B.J., Silbiger R.N., Dusing M.R., Stock J.L., Yager K.L., Potter S.S., Hutton J.J., and Wiginton D.A. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol. Cell. Biol. 12 (1992) 4170-4185
37. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., Weissman S., and Snyder M. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12247-12252
38. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., Piccolboni A., Sementchenko V., Cheng J., Williams A.J., Wheeler R., Wong B., Drenkow J., Yamanaka M., Patel S., Brubaker S., Tammana H., Helt G., Struhl K., and Gingeras T.R. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116 (2004) 499-509
39. Wang Q.F., Lauring J., and Schlissel M.S. c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells. Mol. Cell. Biol. 20 (2000) 9203-9211
40. Braas D., Gundelach H., and Klempnauer K.H. The glioma-amplified sequence 41 gene (GAS41) is a direct Myb target gene. Nucleic Acids Res. 32 (2004) 4750-4757
41. Chayka O., Kintscher J., Braas D., and Klempnauer K.H. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter. Mol. Cell. Biol. 25 (2005) 499-511
42. Kintscher J., Yamkamon V., Braas D., and Klempnauer K.H. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene. Oncogene 23 (2004) 5807-5814
43. Carabana J., Ortigoza E., and Krangel M.S. Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb. J. Immunol. 174 (2005) 4144-4152
44. Geng C.D., and Vedeckis W.V. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J. Biol. Chem. 280 (2005) 43264-43271
45. Ramsay R.G., Ciznadija D., Mantamadiotis T., Anderson R., and Pearson R. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb. Int. J. Biochem. Cell Biol. 37 (2005) 1254-1268
46. Lennartsson A., Garwicz D., Lindmark A., and Gullberg U. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites. Gene 356 (2005) 193-202
47. Chen J., Kremer C.S., and Bender T.P. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Oncogene 25 (2006) 2758-2772
48. Cogswell J.P., Cogswell P.C., Kuehl W.M., Cuddihy A.M., Bender T.M., Engelke U., Marcu K.B., and Ting J.P. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13 (1993) 2858-2869
49. Hogg A., Schirm S., Nakagoshi H., Bartley P., Ishii S., Bishop J.M., and Gonda T.J. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2. Oncogene 15 (1997) 2885-2898
50. Appl H., and Klempnauer K.H. Targeted disruption of c-myb in the chicken pre B-cell line DT40. Oncogene 21 (2002) 3076-3081
51. Wolff L., Schmidt M., Koller R., Haviernik P., Watson R., Bies J., and Maciag K. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells. Blood Cells Mol. Dis. 27 (2001) 483-488
52. Martinez-Chantar M.L., Latasa M.U., Varela-Rey M., Lu S.C., Garcia-Trevijano E.R., Mato J.M., and Avila M.A. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine. J. Biol. Chem. 278 (2003) 19885-19890
53. Zhu W., Giangrande P.H., and Nevins J.R. E2Fs link the control of G1/S and G2/M transcription. EMBO J. 23 (2004) 4615-4626
54. Guerra J., Withers D.A., and Boxer L.M. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. Blood 86 (1995) 1873-1880
55. Lausen J., Liu S., Fliegauf M., Lubbert M., and Werner M.H. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25 (2006) 1349-1357
56. Mao Z., Liu S., Cai J., Huang Z.Z., and Lu S.C. Cloning and functional characterization of the 5′-flanking region of human methionine adenosyltransferase 2A gene. Biochem. Biophys. Res. Commun. 248 (1998) 479-484